Guido Guidi
Director/Board Member chez GENENTA SCIENCE S.P.A.
Fortune : 225 887 $ au 31/03/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Duccio Neri | M | 61 | 28 ans | |
| Pierluigi Paracchi | M | 50 | 10 ans | |
| Mario Zanone Poma | M | 85 |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | - |
| Rajwinder Lehal | M | 48 |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 10 ans |
| Dario Neri | M | 61 | 28 ans | |
| Andrea Recordati | M | 52 | 26 ans | |
| Giovanni Neri | M | 55 | 28 ans | |
| Daniele Scarinci | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 6 ans |
| Federica de Medici | F | 51 | 4 ans | |
| Bastiaan van der Baan | M | 52 |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 3 ans |
| Roberto Ferraresi | M | 48 | 5 ans | |
| Luigi la Corte | M | 54 | 5 ans | |
| Mark Sirgo | M | 70 | 2 ans | |
| Silvia Signoretti | F | - | 1 ans | |
| Richard Peck | M | 73 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 10 ans |
| Giovanni Minora | M | - | 17 ans | |
| Luigi Naldini | M | - | 10 ans | |
| Bernhard Gentner | M | - | 10 ans | |
| Joanna Le Couilliard | F | 60 | 5 ans | |
| Maria Giovanna Calloni | F | 59 | 2 ans | |
| Marta Bavasso | F | 55 | 4 ans | |
| Miro Venturi | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 3 ans |
| Roberto Tascione | M | - |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 8 ans |
| Michaela Castelli | F | 53 | 10 ans | |
| Giampiero Mazza | M | 55 | 6 ans | |
| Robert Koremans | M | 61 | 3 ans | |
| Roger Abravanel | M | 77 | 3 ans | |
| Piergiorgio Peluso | M | 56 | 4 ans | |
| Elisa Corghi | F | 51 | 2 ans | |
| Anthony Marucci | M | 62 | 3 ans | |
| Gianni Marini | M | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Raffaele Sabia | M | - | 7 ans | |
| Gabriele Finzi | M | - | 16 ans | |
| Dario Giusti | M | - |
Italfarmaco SpA
 Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| Paolo Zambonardi | M | - |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| Cathrin Petty | F | 51 | 6 ans | |
| Laura Baldi | F | 52 | - | |
| Emanuele Puca | M | - | - | |
| Holger Neecke | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 2 ans |
| Chiara Zambon | F | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Thibaud Eckenschwiller | M | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 4 ans |
| Stefania Mazzoleni | M | 42 | 8 ans | |
| Maria Lamelas Godinez | F | - | 1 ans | |
| Ilaria Villa | F | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 2 ans |
| Tiziana Pollio | M | - | - | |
| Timothy J. Obara | M | - | 2 ans | |
| Alfredo Covelli | M | - | - | |
| Patrizia Sacchi | F | - | - | |
| Katia Lorizzo | M | - | - | |
| Bibianne Bon | F | - | 1 ans | |
| Ezio Maria Simonelli | M | 66 | - | |
| Roberto Gradnik | M | 68 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 11 ans |
| Karen Chu | M | - |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | - |
| Giovanni Cagnoli | M | 64 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Giacomo di Nepi | M | 72 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Alvise Bonivento | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 8 ans |
| Francesco Granata | M | 73 |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| David Epstein | M | 62 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 2 ans |
| Massimo Tononi | M | 59 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Kim Stratton | F | 62 | 3 ans | |
| Robert Karsunky | M | - |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | - |
| Silvio Inderbitzin | M | 59 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 2 ans |
| Massimiliano Consonni | M | - |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | 5 ans |
| Giovanni Rizzo | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 4 ans |
| Carlo Russo | M | 71 | 3 ans | |
| Witold Urban | M | - | 11 ans | |
| Giorgio de Palma | M | 49 | 4 ans | |
| Leopoldo Giampaolo Zambeletti | M | 55 | - | |
| Nathalie Francesca Dompé | F | 37 | - | |
| Giuseppe Gualazzini | M | 65 | 10 ans | |
| Margherita Zambon | F | 63 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Roberto Teruzzi | M | - | 9 ans | |
| Sergio Gianfranco Dompé | M | 68 | - | |
| Elena Zambon | F | 59 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Richard B. Slansky | M | 67 | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Alfredo Altavilla | M | 60 | 2 ans | |
| Stephen P. Squinto | M | 67 | 1 ans | |
| Riccardo Rosati | M | - |
University of Milan
| 4 ans |
| Mario Colombo | M | 73 |
University of Milan
| 4 ans |
| François Roger | M | 52 |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | 2 ans |
| Gian Giacomo Attolico Trivulzio | M | - |
University of Milan
| 4 ans |
| Marco Brughera | M | 70 |
University of Milan
| 3 ans |
| Ennio Bernasconi | M | - |
University of Milan
| 3 ans |
| Germano Carganico | M | 70 |
University of Milan
| 4 ans |
| Pietro Rossetto | M | 75 |
University of Milan
| 4 ans |
| Paolo Boroli | M | 72 |
University of Milan
| 3 ans |
| Ravi Anand | M | 67 |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | 4 ans |
| Riccardo Dalla-Favera | M | 72 |
University of Milan
| 3 ans |
| Orio Bellezza | M | 65 |
University of Milan
| 4 ans |
| Gianni Camisa | M | - |
University of Milan
| 4 ans |
| Luigi Fumagalli | M | 64 |
University of Milan
| 3 ans |
| Luciano Bonacorsi | M | - |
University of Milan
| 3 ans |
| Michele Zefferino | M | 77 |
University of Milan
| 4 ans |
| Laura Iris Ferro | M | 72 |
University of Milan
| 3 ans |
| Roberto Giovanni Cera | M | 68 |
University of Milan
| 3 ans |
| Paolo Gavazzi | M | 77 |
University of Milan
| 9 ans |
| Daniele Raynaud | M | 65 |
University of Milan
| 4 ans |
| Piero del Soldato | M | - |
University of Milan
| 4 ans |
| Roberto Rettani | M | 71 |
University of Milan
| 4 ans |
| Giorgio Calesella | M | 69 |
University of Milan
| 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Italie | 94 | 94,00% |
| Suisse | 6 | 6,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Guido Guidi
- Réseau Personnel
